Jazz Pharmaceuticals plcJAZZNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
134.99%
↑ 260% above average
Average (39q)
37.48%
Historical baseline
Range
High:2004.74%
Low:-1121.25%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 134.99% |
| Q2 2025 | -676.38% |
| Q1 2025 | -148.42% |
| Q4 2024 | -11.13% |
| Q3 2024 | 27.58% |
| Q2 2024 | 1253.15% |
| Q1 2024 | -115.53% |
| Q4 2023 | -35.87% |
| Q3 2023 | 40.58% |
| Q2 2023 | 50.44% |
| Q1 2023 | 128.93% |
| Q4 2022 | -1121.25% |
| Q3 2022 | -156.68% |
| Q2 2022 | 2004.74% |
| Q1 2022 | 104.66% |
| Q4 2021 | 33.09% |
| Q3 2021 | 85.46% |
| Q2 2021 | -398.21% |
| Q1 2021 | -8.68% |
| Q4 2020 | -10.00% |
| Q3 2020 | 29.12% |
| Q2 2020 | 172.74% |
| Q1 2020 | -313.31% |
| Q4 2019 | -27.65% |
| Q3 2019 | -60.95% |
| Q2 2019 | 207.39% |
| Q1 2019 | -46.57% |
| Q4 2018 | 6.80% |
| Q3 2018 | 61.74% |
| Q2 2018 | 100.74% |
| Q1 2018 | -80.19% |
| Q4 2017 | 265.53% |
| Q3 2017 | -39.85% |
| Q2 2017 | 22.07% |
| Q1 2017 | -25.86% |
| Q4 2016 | 33.90% |
| Q3 2016 | -21.69% |
| Q2 2016 | 50.14% |
| Q1 2016 | -10.44% |
| Q4 2015 | -5.91% |